Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 10/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 10/20 | 0.55 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30637590 | 1.00 | OPRM1 (0.55) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL30637487 | 1.00 | OPRM1 (0.55) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL30637559 | 1.00 | OPRM1 (0.55) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL29519776 | 0.94 | OPRM1 (0.52) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL29519649 | 0.94 | OPRM1 (0.52) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL29519897 | 0.94 | OPRM1 (0.52) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL12148795 | 0.92 | HDAC8 (0.54) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL3205012 | 0.92 | HRH3 (0.53) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL8135311 | 0.92 | HDAC8 (0.54) | OPRM1OPRD1CXCR4OPRK1 | |
| SCHEMBL12809436 | 0.92 | HRH3 (0.53) | OPRM1OPRD1CXCR4OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112789286-B | Carbon-terminal pentapeptide derivative of osteogenic growth peptide, preparation method and application thereof | 陕西慧康生物科技有限责任公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-112789286-B | Carbon-terminal pentapeptide derivative of osteogenic growth peptide, preparation method and application thereof | 陕西慧康生物科技有限责任公司 | 2023-08-29 | — | — | CN | disclosed |